Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1pp9 | SMA | Cytochrome b |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1pp9 | SMA | Cytochrome b | / | 1.000 | |
| 1ppj | SMA | Cytochrome b | / | 0.661 | |
| 3h1j | SMA | Cytochrome b | / | 0.552 | |
| 3cx5 | SMA | Cytochrome b | / | 0.549 | |
| 2qjy | SMA | Cytochrome b | / | 0.532 | |
| 1kyo | SMA | Cytochrome b | / | 0.531 | |
| 1kb9 | SMA | Cytochrome b | / | 0.522 | |
| 3cxh | SMA | Cytochrome b | / | 0.522 | |
| 2yiu | SMA | Cytochrome b | / | 0.520 | |
| 1ezv | SMA | Cytochrome b | / | 0.516 | |
| 2ibz | SMA | Cytochrome b | / | 0.515 | |
| 2qjp | SMA | Cytochrome b | / | 0.505 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.493 | |
| 3dl9 | V2H | Vitamin D 25-hydroxylase | / | 0.487 | |
| 4iui | 1GQ | Estrogen receptor | / | 0.485 | |
| 2nnh | REA | Cytochrome P450 2C8 | / | 0.473 | |
| 4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.466 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.463 | |
| 2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.462 | |
| 3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.462 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.460 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.460 | |
| 4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.458 | |
| 2hqp | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.457 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.454 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.454 | |
| 3rr3 | FLR | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.453 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.450 | |
| 3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.450 | |
| 3stx | BKA | Methylketone synthase I | / | 0.450 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.448 | |
| 3n8w | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.447 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
| 1ie4 | T44 | Transthyretin | / | 0.446 | |
| 2y01 | Y01 | Beta-1 adrenergic receptor | / | 0.446 | |
| 3ad9 | NAD | Subunit alpha of sarocosine oxidase | / | 0.446 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.446 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.446 | |
| 5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.445 | |
| 2bxe | 1FL | Serum albumin | / | 0.444 | |
| 3aba | FLI | Cytochrome P450 | / | 0.444 | |
| 3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.443 | |
| 2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.443 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.443 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.443 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.443 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.442 | |
| 3gcn | TYR_GLN_PHE | Serine endoprotease DegS | 3.4.21.107 | 0.441 | |
| 4g47 | TZF | Mycocyclosin synthase | 1.14.21.9 | 0.441 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.441 | |
| 2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.440 | |
| 3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.440 | |
| 3k1w | BFX | Renin | 3.4.23.15 | 0.440 | |
| 4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.440 |